<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel>
	<title>News on Rebetol from BioPortfolio.com</title>
	<link>http://www.BioPortfolio.com</link>
	<description>Consolidated Rebetol news from BioPortfolio.com</description>
	<pubDate>Tue, 09 Feb 2010 21:48:46 GMT</pubDate>
	<language>en</language>
<atom:link href="http://www.bioportfolio.co.uk/cgi-bin/rssnews.pl?q=Rebetol" rel="self" type="application/rss+xml" />

	
<item><title>In brief: European Medicines agency news</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3962544&amp;HITNO=0&amp;MSIZE=6&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Rebetol&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3962544&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2497342954%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3962544&amp;HITNO=0&amp;MSIZE=6&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Rebetol&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3962544&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2497342954%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharmafocus:</description></item>
<item><title>Ribavirin BioPartners Summary of opinion</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3954841&amp;HITNO=1&amp;MSIZE=6&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Rebetol&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3954841&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2493298622%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3954841&amp;HITNO=1&amp;MSIZE=6&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Rebetol&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3954841&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2493298622%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharma Live:</description></item>
<item><title>EU Panel Backs Conditional Marketing OK For Glaxo's Arepanrix</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3948463&amp;HITNO=2&amp;MSIZE=6&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Rebetol&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3948463&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2488590657%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3948463&amp;HITNO=2&amp;MSIZE=6&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Rebetol&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3948463&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2488590657%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Lloyd's:</description></item>
<item><title>EU Panel Backs Conditional Marketing OK For Glaxo's Arepanrix</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3948417&amp;HITNO=3&amp;MSIZE=6&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Rebetol&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3948417&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2488560995%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3948417&amp;HITNO=3&amp;MSIZE=6&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Rebetol&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3948417&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2488560995%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Morningstar.com:</description></item>
<item><title>EU Panel Backs Conditional Marketing OK For Glaxo's... (DJ)</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3948382&amp;HITNO=4&amp;MSIZE=6&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Rebetol&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3948382&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2488545327%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3948382&amp;HITNO=4&amp;MSIZE=6&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Rebetol&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3948382&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2488545327%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Easy Bourse:</description></item>
<item><title>EU Panel Backs Conditional Marketing OK For Glaxo's Arepanrix</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3948328&amp;HITNO=5&amp;MSIZE=6&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Rebetol&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3948328&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2488529034%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3948328&amp;HITNO=5&amp;MSIZE=6&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Rebetol&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3948328&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2488529034%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>FOXBusiness.com:</description></item>
</channel></rss>